U. Mani

发表

Design, synthesis, and progress toward optimization of potent small molecule antagonists of CC chemokine receptor 8 (CCR8).

C. Zhang, S. Ghosh, B. Jaffee, 2006, Journal of medicinal chemistry.

Normal and abnormal heme biosynthesis. 6. Synthesis and metabolism of a series of monovinylporphyrinogens related to harderoporphyrinogen. Further insights into the oxidative decarboxylation of porphyrinogen substrates by coproporphyrinogen oxidase.

Anna-Sigrid Keck, Marjorie A. Jones, U. Mani, 2010, The Journal of organic chemistry.

Synthetic substrates for coproporophyrinogen oxidase: mesoporphyrinogen-VI revisited

Marjorie A. Jones, U. Mani, T. Lash, 1994 .

Bone-targeted Src kinase inhibitors: novel pyrrolo- and pyrazolopyrimidine analogues.

R. Bohacek, T. Sawyer, W. Shakespeare, 2003, Bioorganic & medicinal chemistry letters.

PRACTICAL SYNTHESIS OF FULLY-SUBSTITUTED PEPTIDE THIAZOLES

D. Holt, U. Mani, J. L. Buchanan, 1999 .

Structure-activity relationships of a novel class of Src SH2 inhibitors.

K. Loiacono, B. Lynch, I. Macneil, 1999, Bioorganic & medicinal chemistry letters.

Unprecedented overmetabolism of a porphyrinogen substrate by coproporphyrinogen oxidase.

Anna-Sigrid Keck, Marjorie A. Jones, U. Mani, 2002, Bioorganic & medicinal chemistry letters.

Normal and abnormal heme biosynthesis. 3.(1)Synthesis and metabolism of tripropionate analogues of coproporphyrinogen-III: novel probes for the active site of coproporphyrinogen oxidase.

T. Hall, M. Jones, U. Mani, 2001, The Journal of organic chemistry.

Normal and Abnormal Heme Biosynthesis. 2.1 Synthesis and Metabolism of Type-III Pentacarboxylic Porphyrinogens: Further Experimental Evidence for the Enzymic Clockwise Decarboxylation of Uroporphyrinogen-III

Marjorie A. Jones, U. Mani, Elizabeth A. Lyons, 1999 .

Normal and Abnormal Heme Biosynthesis. 1. Synthesis and Metabolism of Di- and Monocarboxylic Porphyrinogens Related to Coproporphyrinogen-III and Harderoporphyrinogen: A Model for the Active Site of Coproporphyrinogen Oxidase

T. Hall, Marjorie A. Jones, U. Mani, 1999 .

Bone-targeted 2,6,9-trisubstituted purines: novel inhibitors of Src tyrosine kinase for the treatment of bone diseases.

R. Bohacek, T. Sawyer, W. Shakespeare, 2003, Bioorganic & medicinal chemistry letters.